Key environmental exposure pathways to antimicrobial resistant bacteria in southern Malawi: A SaniPath approach

Taonga Mwapasa1, Kondwani Chidziwisano2, Madalitso Mphasa3

  • 1Centre for Water, Sanitation, Health, and Appropriate Technology Development (WASHTED), Malawi University of Business and Applied Sciences, Blantyre, Malawi.

Insights

Antimicrobial resistance (AMR) spreads through community environments in Malawi, particularly in urban areas and through drains and soil. Poor sanitation and seasonal factors significantly increase the prevalence of extended-spectrum β-lactamase (ESBL) producing bacteria.

Area of Science:

  • Environmental microbiology
  • Public health
  • Infectious disease epidemiology

Background:

  • Antimicrobial resistance (AMR) is a critical global health challenge.
  • Transmission pathways of AMR in communal environments are not well understood.
  • This study focuses on extended-spectrum β-lactamase (ESBL) producing bacteria in Malawi.

Purpose of the Study:

  • To investigate AMR risk pathways, prevalence, and seasonality of ESBL-producing E. coli and K. pneumoniae in Malawi.
  • To identify practices contributing to environmental contamination.
  • To inform interventions for AMR control in communal settings.

Main Methods:

  • Utilized the SaniPath tool for transect walks to identify exposure pathways.
  • Collected 1440 environmental samples over 12 months from urban, peri-urban, and rural sites.
  • Employed microbiological analysis using chromogenic agar to detect ESBL-producing bacteria.

Main Results:

  • Highest ESBL prevalence observed in urban environments (68.1%) and specific pathways like drains (58.8%) and soil (54.1%).
  • Environmental contamination linked to poor sanitation and hygiene infrastructure.
  • ESBL prevalence showed seasonal variation, peaking in the hot-dry season and increasing with rainfall.

Conclusions:

  • Communal environments are significant reservoirs for AMR transmission, with ESBL bacteria abundant in exposure pathways.
  • Inadequate sanitation infrastructure and practices, alongside seasonal dynamics, exacerbate ESBL presence.
  • A comprehensive, systems-level approach addressing infrastructure, behavior, and surveillance is crucial for AMR mitigation.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...